Cargando…
A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837585/ https://www.ncbi.nlm.nih.gov/pubmed/36686023 http://dx.doi.org/10.5114/ada.2022.122609 |
| _version_ | 1784869113860980736 |
|---|---|
| author | Hayama, Koremasa Izaki, Satoshi Hayashi, Kentaro Kurosawa, Yusuke Yamada, Shiho Shimizu, Tetsuo Gon, Yasuhiro Fujita, Hideki |
| author_facet | Hayama, Koremasa Izaki, Satoshi Hayashi, Kentaro Kurosawa, Yusuke Yamada, Shiho Shimizu, Tetsuo Gon, Yasuhiro Fujita, Hideki |
| author_sort | Hayama, Koremasa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9837585 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Termedia Publishing House |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98375852023-01-20 A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration Hayama, Koremasa Izaki, Satoshi Hayashi, Kentaro Kurosawa, Yusuke Yamada, Shiho Shimizu, Tetsuo Gon, Yasuhiro Fujita, Hideki Postepy Dermatol Alergol Letter to the Editor Termedia Publishing House 2022-12-22 2022-12 /pmc/articles/PMC9837585/ /pubmed/36686023 http://dx.doi.org/10.5114/ada.2022.122609 Text en Copyright: © 2022 Termedia Sp. z o. o. https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
| spellingShingle | Letter to the Editor Hayama, Koremasa Izaki, Satoshi Hayashi, Kentaro Kurosawa, Yusuke Yamada, Shiho Shimizu, Tetsuo Gon, Yasuhiro Fujita, Hideki A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration |
| title | A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration |
| title_full | A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration |
| title_fullStr | A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration |
| title_full_unstemmed | A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration |
| title_short | A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration |
| title_sort | case of acute exacerbation of chronic spontaneous urticaria due to covid-19 immediately after omalizumab administration |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837585/ https://www.ncbi.nlm.nih.gov/pubmed/36686023 http://dx.doi.org/10.5114/ada.2022.122609 |
| work_keys_str_mv | AT hayamakoremasa acaseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT izakisatoshi acaseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT hayashikentaro acaseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT kurosawayusuke acaseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT yamadashiho acaseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT shimizutetsuo acaseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT gonyasuhiro acaseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT fujitahideki acaseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT hayamakoremasa caseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT izakisatoshi caseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT hayashikentaro caseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT kurosawayusuke caseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT yamadashiho caseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT shimizutetsuo caseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT gonyasuhiro caseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration AT fujitahideki caseofacuteexacerbationofchronicspontaneousurticariaduetocovid19immediatelyafteromalizumabadministration |